首頁 > 市場調查報告書 > 醫療設備

心血管設備電子醫療設備

市場調查報告書

商品編碼

1489258

全球心血管數位健康市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Digital Health For Cardiovascular Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 131 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球心血管數位健康市場需求預計將從 2023 年的 410.7 億美元達到近 2,591 億美元的市場規模，2024-2032 年研究期間複合年成長率為 22.71%。

心血管護理的數位健康包括使用數位技術來監測、診斷和管理心臟相關疾病。這包括穿戴式裝置、行動健康應用程式、遠距醫療和電子健康記錄，它們提供心率、血壓和其他生命徵象的持續監測和即時資料。這些技術能夠及早發現心血管問題，制定個人化治療計劃，並提高患者對藥物和生活方式改變的依從性。數位健康工具增強患者參與度，促進遠距諮詢，並允許及時干預，最終旨在改善心血管結果並減輕醫療系統的心臟病負擔。

市場動態

心血管市場的數位健康是由全球心血管疾病盛行率不斷擴大推動的，因此需要更好的管理和監測解決方案。穿戴式裝置和遠端監測系統等數位健康技術的進步透過提供即時資料和改善患者治療結果徹底改變了心血管護理。遠距醫療的日益普及，尤其是在 COVID-19 大流行期間，極大地提振了市場。此外，人工智慧和機器學習在數位健康工具中的整合，用於預測分析和個人化治療計劃，進一步推動了市場的發展。政府對數位健康創新的舉措和資助以及人們對預防性醫療保健意識的不斷提高也是推動心血管市場數位健康的關鍵因素。然而，資料隱私問題和互通性挑戰可能會在未來幾年挑戰心血管市場數位健康的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球心血管數位健康市場的各個細分市場進行了包容性評估。心血管行業數位健康的成長和趨勢為本研究提供了整體方法。

市場區隔

心血管數位健康市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按組件

軟體
硬體
服務

按最終用途

患者
供應商
付款人
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲心血管數位健康市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。心血管數位健康市場的主要參與者包括 Orange Business、GE Healthcare、健康資訊管理系統 (HIMS)、蘋果、西門子 Healthineers AG、甲骨文 (Cerner Corporation)、NXGN Management LLC、三星、Doven、CardiAI、AliveCor Inc. 、Verily Life Sciences LLC、HeartFlow Inc.、Bardy Diagnostics Inc.、Vista AI、Viz Ai、RSIP Vision、Cleerly Inc.。未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：心血管公司數位健康的競爭格局

心血管市場競爭的數位健康
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Orange Business

公司簡介
公司收入
產品
最近的發展

GE Healthcare

公司簡介
公司收入
產品
最近的發展

Health Information Management Systems (HIMS)

公司簡介
公司收入
產品
最近的發展

Apple Inc.

公司簡介
公司收入
產品
最近的發展

Siemens Healthineers AG

公司簡介
公司收入
產品
最近的發展

Oracle (Cerner Corporation)

公司簡介
公司收入
產品
最近的發展

NXGN Management LLC

公司簡介
公司收入
產品
最近的發展

Samsung

公司簡介
公司收入
產品
最近的發展

Doven

公司簡介
公司收入
產品
最近的發展

CardiAI

公司簡介
公司收入
產品
最近的發展

AliveCor Inc.

公司簡介
公司收入
產品
最近的發展

Verily Life Sciences LLC

公司簡介
公司收入
產品
最近的發展

HeartFlow Inc.

公司簡介
公司收入
產品
最近的發展

Bardy Diagnostics Inc.

公司簡介
公司收入
產品
最近的發展

Vista AI

公司簡介
公司收入
產品
最近的發展

Viz Ai

公司簡介
公司收入
產品
最近的發展

RSIP Vision

公司簡介
公司收入
產品
最近的發展

Cleerly Inc

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114727

The global demand for Digital Health For Cardiovascular Market is presumed to reach the market size of nearly USD 259.1 Billion by 2032 from USD 41.07 Billion in 2023 with a CAGR of 22.71% under the study period 2024-2032.

Digital health for cardiovascular care encompasses using digital technologies to monitor, diagnose, and manage heart-related conditions. This includes wearable devices, mobile health apps, telemedicine, and electronic health records, which provide continuous monitoring and real-time data on heart rate, blood pressure, and other vital signs. These technologies enable early detection of cardiovascular issues, personalized treatment plans, and improved patient adherence to medication and lifestyle changes. Digital health tools enhance patient engagement, facilitate remote consultations, and allow for timely interventions, ultimately aiming to enhance cardiovascular outcomes and lower the burden of heart disease on healthcare systems.

MARKET DYNAMICS

The digital health for the cardiovascular market is driven by the expanding prevalence of cardiovascular diseases worldwide, necessitating better management and monitoring solutions. Advances in digital health technologies, such as wearable devices and remote monitoring systems, have revolutionized cardiovascular care by providing real-time data and enhancing patient outcomes. The increasing adoption of telemedicine, especially during the COVID-19 pandemic, has significantly boosted the market. Additionally, the integration of artificial intelligence & machine learning in digital health tools for predictive analytics and personalized treatment plans has further propelled the market. Government initiatives and funding for digital health innovations and the rising awareness about preventive healthcare are also key factors driving digital health for the cardiovascular market. However, data privacy concerns and interoperability challenges may challenge the growth of digital health for the cardiovascular market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Digital Health For Cardiovascular. The growth and trends of Digital Health For Cardiovascular industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Digital Health For Cardiovascular market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Component

Software
Hardware
Services

By End-use

Patients
Providers
Payers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Digital Health For Cardiovascular market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Digital Health For Cardiovascular market include Orange Business, GE Healthcare, Health Information Management Systems (HIMS), Apple Inc., Siemens Healthineers AG, Oracle (Cerner Corporation), NXGN Management LLC, Samsung, Doven, CardiAI, AliveCor Inc., Verily Life Sciences LLC, HeartFlow Inc., Bardy Diagnostics Inc., Vista AI, Viz Ai, RSIP Vision, Cleerly Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. DIGITAL HEALTH FOR CARDIOVASCULAR - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Component
- 3.7.2 Market Attractiveness Analysis By End-use
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET ANALYSIS BY COMPONENT

5.1. Overview By Component
5.2. Historical and Forecast Data Analysis By Component
5.3. Software Historic and Forecast Sales By Regions
5.4. Hardware Historic and Forecast Sales By Regions
5.5. Services Historic and Forecast Sales By Regions

6. GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET ANALYSIS BY END-USE

6.1. Overview By End-use
6.2. Historical and Forecast Data Analysis By End-use
6.3. Patients Historic and Forecast Sales By Regions
6.4. Providers Historic and Forecast Sales By Regions
6.5. Payers Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE DIGITAL HEALTH FOR CARDIOVASCULAR COMPANIES

8.1. Digital Health For Cardiovascular Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF DIGITAL HEALTH FOR CARDIOVASCULAR INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Orange Business
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. GE Healthcare
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Health Information Management Systems (HIMS)
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Apple Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Siemens Healthineers AG
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Oracle (Cerner Corporation)
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. NXGN Management LLC
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Samsung
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Doven
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. CardiAI
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. AliveCor Inc.
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments
9.14. Verily Life Sciences LLC
- 9.14.1 Company Overview
- 9.14.2 Company Revenue
- 9.14.3 Products
- 9.14.4 Recent Developments
9.15. HeartFlow Inc.
- 9.15.1 Company Overview
- 9.15.2 Company Revenue
- 9.15.3 Products
- 9.15.4 Recent Developments
9.16. Bardy Diagnostics Inc.
- 9.16.1 Company Overview
- 9.16.2 Company Revenue
- 9.16.3 Products
- 9.16.4 Recent Developments
9.17. Vista AI
- 9.17.1 Company Overview
- 9.17.2 Company Revenue
- 9.17.3 Products
- 9.17.4 Recent Developments
9.18. Viz Ai
- 9.18.1 Company Overview
- 9.18.2 Company Revenue
- 9.18.3 Products
- 9.18.4 Recent Developments
9.19. RSIP Vision
- 9.19.1 Company Overview
- 9.19.2 Company Revenue
- 9.19.3 Products
- 9.19.4 Recent Developments
9.20. Cleerly Inc
- 9.20.1 Company Overview
- 9.20.2 Company Revenue
- 9.20.3 Products
- 9.20.4 Recent Developments